Daiichi Sankyo's ADC Alliances Test Valuation Gap In Oncology Strategy [Yahoo! Finance]
DAIICHI SANKYO S/ADR (DSNKY)
NASDAQ:AMEX Investor Relations:
daiichisankyo.com/media_investors/investor_relations/index.html
Company Research
Source: Yahoo! Finance
Daiichi Sankyo Company (TSE:4568) has entered a collaboration with Tempus AI to apply AI models to patient selection and biomarker discovery in oncology. The company has also announced research collaborations with Leveragen for next generation in vivo platforms and Voro Therapeutics for masked ADC technologies. These agreements focus on accelerating antibody drug conjugate research and development across oncology programs. Daiichi Sankyo shares last closed at ¥2,930.0, with the stock showing a 17.0% decline year to date and a 19.2% decline over the past year. Over a 3 year period, the share price shows a 37.0% decline, while the 5 year return is close to flat at a 0.7% decline. Against this backdrop, the new ADC focused collaborations may be important for investors who are monitoring how the company positions its oncology pipeline. For readers following TSE:4568, these agreements highlight a clear emphasis on biologics and targeted cancer therapies, with Tempus AI contributin
Show less
Read more
Impact Snapshot
Event Time:
DSNKY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSNKY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSNKY alerts
High impacting DAIICHI SANKYO S/ADR news events
Weekly update
A roundup of the hottest topics
DSNKY
News
- ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation [Yahoo! Finance]Yahoo! Finance
- Can Tempus AI's (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? [Yahoo! Finance]Yahoo! Finance
- Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo [Seeking Alpha]Seeking Alpha
- Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity [Yahoo! Finance]Yahoo! Finance
- Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical ProgramBusiness Wire